81 related articles for article (PubMed ID: 15155249)
1. Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1.
Wainberg MA; Brenner BG; Daar E; Gertner JM; Olivier C; Kenley S
Antimicrob Agents Chemother; 2004 Jun; 48(6):2337-40. PubMed ID: 15155249
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
3. Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages.
Ewart GD; Nasr N; Naif H; Cox GB; Cunningham AL; Gage PW
Antimicrob Agents Chemother; 2004 Jun; 48(6):2325-30. PubMed ID: 15155246
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL.
Zhang M; Huang Q; Huang Y; Wood O; Yuan W; Chancey C; Daniel S; Rios M; Hewlett I; Clouse KA; Dayton AI
Retrovirology; 2008 Sep; 5():82. PubMed ID: 18808673
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycin.
Georgiou NA; van der Bruggen T; Oudshoorn M; de Bie P; Jansen CA; Nottet HS; Marx JJ; van Asbeck BS
Antiviral Res; 2004 Aug; 63(2):97-106. PubMed ID: 15302138
[TBL] [Abstract][Full Text] [Related]
7. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.
Blair WS; Cao J; Jackson L; Jimenez J; Peng Q; Wu H; Isaacson J; Butler SL; Chu A; Graham J; Malfait AM; Tortorella M; Patick AK
Antimicrob Agents Chemother; 2007 Oct; 51(10):3554-61. PubMed ID: 17646410
[TBL] [Abstract][Full Text] [Related]
9. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
[TBL] [Abstract][Full Text] [Related]
10. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
Yu LJ; Ma RD; Jiang SB
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099
[TBL] [Abstract][Full Text] [Related]
11. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H
J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
13. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K
J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358
[TBL] [Abstract][Full Text] [Related]
14. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.
Bleiber G; Munoz M; Ciuffi A; Meylan P; Telenti A
J Virol; 2001 Apr; 75(7):3291-300. PubMed ID: 11238855
[TBL] [Abstract][Full Text] [Related]
15. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
17. [In vitro pharmacodynamics study of an anti-HIV Chinese herbal formulation].
Li ZL; Zeng Y; Su LS; Zhang XM; Shao YM; Zeng X; Wolf H; Zeng Y
Yao Xue Xue Bao; 2010 Feb; 45(2):253-6. PubMed ID: 21351436
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of Hebei HIV-1 p24 kit for the detection of human immunodeficiency virus].
Yang YS; Wang RT; Zhang XG; Zhang HZ; Wang HF; Li ZL; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):8-10. PubMed ID: 17429521
[TBL] [Abstract][Full Text] [Related]
19. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
Zheng YT; Ben KL; Jin SW
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Hirsch MS; Brun-Vézinet F; Clotet B; Conway B; Kuritzkes DR; D'Aquila RT; Demeter LM; Hammer SM; Johnson VA; Loveday C; Mellors JW; Jacobsen DM; Richman DD
Clin Infect Dis; 2003 Jul; 37(1):113-28. PubMed ID: 12830416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
